Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 | 1.000 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.673 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.648 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.632 | |
| 3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.624 | |
| 1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.614 | |
| 1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.613 | |
| 2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.613 | |
| 1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.607 | |
| 4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.607 | |
| 3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.599 | |
| 4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.589 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.588 | |
| 2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.586 | |
| 3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.585 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.583 | |
| 4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.583 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.581 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.579 | |
| 3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.578 | |
| 4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.578 | |
| 2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.577 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.576 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.575 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.575 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.573 | |
| 2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.573 | |
| 3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.573 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.573 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.572 | |
| 2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.571 | |
| 3ac2 | KSE | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.569 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.567 | |
| 4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.567 | |
| 4lgg | VGG | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.566 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.565 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.564 | |
| 2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.563 | |
| 2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.563 | |
| 3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.563 | |
| 2itw | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.559 | |
| 4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.559 | |
| 2f4j | VX6 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.558 | |
| 2xyn | VX6 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.556 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.556 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.556 | |
| 4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.555 | |
| 2pzp | ACP | Fibroblast growth factor receptor 2 | / | 0.554 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.553 | |
| 2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.553 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.553 | |
| 4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.552 | |
| 2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.550 | |
| 2vww | 7X2 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.550 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.550 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.550 | |
| 2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.549 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.549 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.549 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.548 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.548 | |
| 4lgh | 0JN | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.548 | |
| 2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.547 | |
| 4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.547 | |
| 4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.547 | |
| 2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.546 | |
| 2q0b | ACP | Fibroblast growth factor receptor 2 | / | 0.545 | |
| 2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.545 | |
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.544 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.544 | |
| 4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.543 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.543 | |
| 4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.543 | |
| 1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.542 | |
| 4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.542 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.542 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.541 | |
| 2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.539 | |
| 2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.539 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.537 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.537 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.537 | |
| 1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.536 | |
| 2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 0.536 | |
| 2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.536 | |
| 3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.536 | |
| 2itv | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.534 | |
| 4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.534 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.532 | |
| 4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.532 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.531 | |
| 2gs7 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.531 | |
| 4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.531 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.530 | |
| 5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.530 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.529 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.529 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.528 | |
| 2eb3 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.527 | |
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.527 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.526 | |
| 4aa4 | QC0 | Mitogen-activated protein kinase 14 | / | 0.526 | |
| 1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.525 | |
| 4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.525 | |
| 2ivv | PP1 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.524 | |
| 2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.524 | |
| 2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.523 | |
| 3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.523 | |
| 2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.522 | |
| 2pz5 | ACP | Fibroblast growth factor receptor 2 | / | 0.522 | |
| 2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.522 | |
| 3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.522 | |
| 2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.521 | |
| 2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.521 | |
| 4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.521 | |
| 3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.520 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.519 | |
| 3mvm | 39P | Mitogen-activated protein kinase 14 | / | 0.518 | |
| 4kiq | 1RA | Mitogen-activated protein kinase 14 | / | 0.518 | |
| 5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.518 | |
| 4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.517 | |
| 3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.516 | |
| 3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.516 | |
| 4btk | DTQ | Tau-tubulin kinase 1 | 2.7.11.1 | 0.516 | |
| 4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.515 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.515 | |
| 2pzr | ACP | Fibroblast growth factor receptor 2 | / | 0.514 | |
| 4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.514 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.513 | |
| 1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.513 | |
| 4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.513 | |
| 4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.512 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.510 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.510 | |
| 4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.510 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.510 | |
| 2hzi | JIN | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.509 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.509 | |
| 2g2f | AGS | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.507 | |
| 2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.507 | |
| 3nbw | TR4 | Ketohexokinase | / | 0.507 | |
| 4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.507 | |
| 5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.507 | |
| 2itu | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.506 | |
| 3fsk | RO6 | Mitogen-activated protein kinase 14 | / | 0.506 | |
| 4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.506 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.506 | |
| 2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.505 | |
| 2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.505 | |
| 3iph | G11 | Mitogen-activated protein kinase 14 | / | 0.505 | |
| 4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.505 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.505 | |
| 2x2k | X2K | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.504 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.503 | |
| 2i0e | PDS | Protein kinase C beta type | 2.7.11.13 | 0.503 | |
| 3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.503 | |
| 3tuc | FPW | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.503 | |
| 4fnz | NZF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.502 | |
| 2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.500 | |
| 3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.500 | |
| 2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.499 | |
| 2x2l | X2L | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.499 | |
| 2zb0 | GK3 | Mitogen-activated protein kinase 14 | / | 0.499 | |
| 3acj | KSS | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.498 | |
| 2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.497 | |
| 3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.497 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.497 | |
| 1di9 | MSQ | Mitogen-activated protein kinase 14 | / | 0.496 | |
| 1py5 | PY1 | TGF-beta receptor type-1 | 2.7.11.30 | 0.496 | |
| 4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.496 | |
| 5iu8 | 6DZ | Adenosine receptor A2a | / | 0.496 | |
| 2itx | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.495 | |
| 3rwp | ABQ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.495 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.495 | |
| 1e90 | MYC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.494 | |
| 1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.494 | |
| 1u54 | ACP | Activated CDC42 kinase 1 | / | 0.494 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.494 | |
| 4app | N53 | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.494 | |
| 4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.494 | |
| 1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.493 | |
| 2rg6 | 287 | Mitogen-activated protein kinase 14 | / | 0.493 | |
| 4eqc | XR1 | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.493 | |
| 2c3k | ABO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.492 | |
| 2xf0 | 4UB | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.492 | |
| 3prf | FP3 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.492 | |
| 4fsq | HK3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.492 | |
| 4jvf | 17X | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.492 | |
| 2zm4 | KSM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.491 | |
| 3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.491 | |
| 4bdh | WVI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.491 | |
| 2oiq | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.490 | |
| 5c8w | PCG | cGMP-dependent protein kinase 2 | 2.7.11.12 | 0.490 | |
| 1ouy | 094 | Mitogen-activated protein kinase 14 | / | 0.489 | |
| 1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.489 | |
| 2gtn | LIE | Mitogen-activated protein kinase 14 | / | 0.489 | |
| 2i1m | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.489 | |
| 2ww4 | ADP | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase | 2.7.1.148 | 0.489 | |
| 1ove | 358 | Mitogen-activated protein kinase 14 | / | 0.488 | |
| 3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.488 | |
| 4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.488 | |
| 4u9a | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.488 | |
| 5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.488 | |
| 2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.487 | |
| 3flw | FLW | Mitogen-activated protein kinase 14 | / | 0.487 | |
| 3l8x | N4D | Mitogen-activated protein kinase 14 | / | 0.487 | |
| 3cjf | SAV | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.486 | |
| 3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.486 | |
| 4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.486 | |
| 5iub | CLR | Adenosine receptor A2a | / | 0.486 | |
| 1e8z | STU | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.485 | |
| 2pvy | ACP | Fibroblast growth factor receptor 2 | / | 0.485 | |
| 3ppk | FNI | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.485 | |
| 4fst | HK4 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.485 | |
| 4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.485 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.485 | |
| 2j0j | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.484 | |
| 3oct | 1N1 | Tyrosine-protein kinase BTK | 2.7.10.2 | 0.484 | |
| 3v3v | MYU | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.484 | |
| 4mf0 | 29Z | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.484 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.483 | |
| 2wmx | ZY6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.483 | |
| 3ocg | OCG | Mitogen-activated protein kinase 14 | / | 0.483 | |
| 3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.483 | |
| 3qri | 919 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.483 | |
| 4ckj | ADN | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.483 | |
| 4qmw | KS1 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.483 | |
| 5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.483 | |
| 1zrz | BI1 | Protein kinase C iota type | 2.7.11.13 | 0.482 | |
| 3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.482 | |
| 1oec | AA2 | Fibroblast growth factor receptor 2 | / | 0.481 | |
| 3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.481 | |
| 4ezl | 0SE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.481 | |
| 4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.481 | |
| 4lm5 | Q17 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.481 | |
| 1agw | SU2 | Fibroblast growth factor receptor 1 | / | 0.480 | |
| 1m7q | DQO | Mitogen-activated protein kinase 14 | / | 0.480 | |
| 2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.480 | |
| 2yer | TQ1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.480 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.480 | |
| 4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.480 | |
| 4nfn | 2KC | Tau-tubulin kinase 1 | 2.7.11.1 | 0.480 | |
| 1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.479 | |
| 1zz2 | B11 | Mitogen-activated protein kinase 14 | / | 0.479 | |
| 2gqg | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.479 | |
| 2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.479 | |
| 3u4u | LNH | Casein kinase II subunit alpha | 2.7.11.1 | 0.479 | |
| 4bdf | H3R | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.479 | |
| 4ftk | H9K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.479 | |
| 4ftm | 1HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.479 | |
| 1phg | MYT | Camphor 5-monooxygenase | 1.14.15.1 | 0.478 | |
| 1rw8 | 580 | TGF-beta receptor type-1 | 2.7.11.30 | 0.478 | |
| 2baq | PQB | Mitogen-activated protein kinase 14 | / | 0.478 | |
| 2chz | 093 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.478 | |
| 2wle | COA | Polysialic acid O-acetyltransferase | / | 0.478 | |
| 4b8w | NAP | GDP-L-fucose synthase | 1.1.1.271 | 0.478 | |
| 4f9w | LM4 | Mitogen-activated protein kinase 14 | / | 0.478 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.478 | |
| 5iua | 6DX | Adenosine receptor A2a | / | 0.478 | |
| 2c47 | 5ID | Casein kinase I isoform gamma-2 | / | 0.477 | |
| 2jed | LG8 | Protein kinase C theta type | 2.7.11.13 | 0.477 | |
| 2vtt | LZD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.477 | |
| 3fls | FLS | Mitogen-activated protein kinase 14 | / | 0.477 | |
| 4fex | 0TO | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.477 | |
| 4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.477 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.477 | |
| 1lso | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.476 | |
| 2e9p | 77A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.476 | |
| 2p5u | NAD | UDP-glucose 4-epimerase | / | 0.476 | |
| 2rg5 | 279 | Mitogen-activated protein kinase 14 | / | 0.476 | |
| 3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.476 | |
| 3ocs | 746 | Tyrosine-protein kinase BTK | 2.7.10.2 | 0.476 | |
| 4l3j | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.476 | |
| 2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.475 | |
| 2ym7 | YM7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.475 | |
| 3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.475 | |
| 3emg | 685 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.475 | |
| 3qcy | 3Q3 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.475 | |
| 3w2o | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.475 | |
| 4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.475 | |
| 4cki | ADN | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.475 | |
| 4fyo | 0VF | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.475 | |
| 1qvn | FRI | Interleukin-2 | / | 0.474 | |
| 2cgx | 3D3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.474 | |
| 2wmu | ZYU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.474 | |
| 2wmw | ZYW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.474 | |
| 3b2t | M33 | Fibroblast growth factor receptor 2 | / | 0.474 | |
| 3zok | NAD | 3-dehydroquinate synthase, chloroplastic | 4.2.3.4 | 0.474 | |
| 4ewn | 0VR | Imidazole glycerol phosphate synthase subunit HisF | 4.1.3 | 0.474 | |
| 2e9v | 85A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.473 | |
| 2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.473 | |
| 4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.473 | |
| 4ezj | 0SC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.473 | |
| 4hnf | 16W | Casein kinase I isoform delta | 2.7.11.1 | 0.473 | |
| 4o76 | 1M3 | Bromodomain-containing protein 4 | / | 0.473 | |
| 2fhn | BNI | Avidin-related protein 4/5 | / | 0.472 | |
| 2q7v | FAD | Thioredoxin reductase | / | 0.472 | |
| 2ydk | YDK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.472 | |
| 3be2 | RAJ | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.472 | |
| 3fly | FLY | Mitogen-activated protein kinase 14 | / | 0.472 | |
| 3mpt | 1GK | Mitogen-activated protein kinase 14 | / | 0.472 | |
| 3q3b | 55E | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.472 | |
| 4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.472 | |
| 1k6t | XN1 | Gag-Pol polyprotein | 3.4.23.16 | 0.471 | |
| 2ghm | LIC | Mitogen-activated protein kinase 14 | / | 0.471 | |
| 2x2m | X2M | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.471 | |
| 3s2a | 2NQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.471 | |
| 3she | I85 | MAP kinase-activated protein kinase 3 | 2.7.11.1 | 0.471 | |
| 4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.471 | |
| 4dce | 0JF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.471 | |
| 4fsz | HK8 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.471 | |
| 4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.471 | |
| 4iwo | 1H4 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.471 | |
| 4kin | 1M8 | Mitogen-activated protein kinase 14 | / | 0.471 | |
| 4mvf | STU | Calcium-dependent protein kinase 2 | 2.7.11.1 | 0.471 | |
| 5iu4 | ZMA | Adenosine receptor A2a | / | 0.471 | |
| 2buj | STU | Serine/threonine-protein kinase 16 | / | 0.470 | |
| 2uw0 | GVK | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.470 | |
| 3e92 | G6A | Mitogen-activated protein kinase 14 | / | 0.470 | |
| 3h9f | 92M | Dual specificity protein kinase TTK | 2.7.12.1 | 0.470 | |
| 3roc | 29A | Mitogen-activated protein kinase 14 | / | 0.470 | |
| 4a30 | QMI | Glycylpeptide N-tetradecanoyltransferase | / | 0.470 | |
| 4anv | 751 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.470 | |
| 4few | PP2 | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.470 | |
| 1y0s | 331 | Peroxisome proliferator-activated receptor delta | / | 0.469 | |
| 2brb | PFQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.469 | |
| 3fmk | FMK | Mitogen-activated protein kinase 14 | / | 0.469 | |
| 3oqk | S52 | Renin | 3.4.23.15 | 0.469 | |
| 3uib | SB2 | Putative mitogen-activated protein kinase | / | 0.469 | |
| 3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.469 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.469 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.469 | |
| 4ct1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.469 | |
| 4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.469 | |
| 4ftu | 7HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.469 | |
| 4gh2 | HK0 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.469 | |
| 4kip | 1R9 | Mitogen-activated protein kinase 14 | / | 0.469 | |
| 4qna | X11 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.469 | |
| 1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
| 1q4l | 679 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.468 | |
| 2ilt | NN1 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.468 | |
| 2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.468 | |
| 3gc7 | B45 | Mitogen-activated protein kinase 14 | / | 0.468 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.468 | |
| 3gu8 | 3GU | Death-associated protein kinase 1 | 2.7.11.1 | 0.468 | |
| 3hp5 | 52P | Mitogen-activated protein kinase 14 | / | 0.468 | |
| 3il1 | B5D | Glutamate receptor 2 | / | 0.468 | |
| 3r04 | UNQ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.468 | |
| 3r8l | Z30 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
| 3zw3 | ZW3 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.468 | |
| 4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.468 | |
| 4f65 | 0S9 | Fibroblast growth factor receptor 1 | / | 0.468 | |
| 4fsw | HK6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
| 4fsy | HK7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
| 4ftc | H6K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
| 4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.468 | |
| 4nmb | FAD | Bifunctional protein PutA | / | 0.468 | |
| 4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.468 | |
| 5k2d | ZMA | Adenosine receptor A2a | / | 0.468 | |
| 1m52 | P17 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.467 | |
| 2brh | DFW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
| 2qhm | 7CS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
| 3d7z | GK5 | Mitogen-activated protein kinase 14 | / | 0.467 | |
| 3gfe | P37 | Mitogen-activated protein kinase 14 | / | 0.467 | |
| 3vjn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.467 | |
| 4a32 | 2CD | Glycylpeptide N-tetradecanoyltransferase | / | 0.467 | |
| 4b7t | CWT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.467 | |
| 4l4x | NDP | AmphI | / | 0.467 | |
| 5cvh | ADP | Casein kinase II subunit alpha | 2.7.11.1 | 0.467 | |
| 1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.466 | |
| 2bfy | H1N | Aurora kinase B-A | 2.7.11.1 | 0.466 | |
| 2e9u | A25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
| 2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.466 | |
| 2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.466 | |
| 2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.466 | |
| 2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.466 | |
| 2ym3 | YM3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
| 3at4 | CCK | Casein kinase II subunit alpha | 2.7.11.1 | 0.466 | |
| 3pjc | PJC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.466 | |
| 3vo3 | 0KF | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.466 | |
| 4agu | D15 | Cyclin-dependent kinase-like 1 | / | 0.466 | |
| 4b8z | NAP | GDP-L-fucose synthase | 1.1.1.271 | 0.466 | |
| 4gj2 | 0XH | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.466 | |
| 4q5j | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.466 | |
| 4rrv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.466 | |
| 5jtb | ZMA | Adenosine receptor A2a | / | 0.466 | |
| 1e6e | FAD | NADPH:adrenodoxin oxidoreductase, mitochondrial | 1.18.1.6 | 0.465 | |
| 1ke5 | LS1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
| 1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.465 | |
| 1rfv | ADP | Pyridoxal kinase | 2.7.1.35 | 0.465 | |
| 2i0z | FAD | NAD(FAD)-utilizing dehydrogenases | / | 0.465 | |
| 3e8e | G98 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.465 | |
| 3i5z | Z48 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.465 | |
| 3k3h | BYE | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.465 | |
| 3qaq | QAQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.465 | |
| 3vw6 | IM6 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.465 | |
| 4aqc | 88A | Tyrosine-protein kinase JAK2 | / | 0.465 | |
| 4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.465 | |
| 4fuy | EK2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.465 | |
| 4gkh | 0J9 | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.465 | |
| 4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.465 | |
| 4ih8 | B43 | Calmodulin-domain protein kinase 1 | / | 0.465 | |
| 5dr9 | SKE | Aurora kinase A | 2.7.11.1 | 0.465 | |
| 1ckp | PVB | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
| 1snu | STU | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.464 | |
| 2g2h | P16 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.464 | |
| 2i40 | BLZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
| 2rl5 | 2RL | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.464 | |
| 3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.464 | |
| 3fl4 | FL4 | Mitogen-activated protein kinase 14 | / | 0.464 | |
| 3flz | FLZ | Mitogen-activated protein kinase 14 | / | 0.464 | |
| 3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.464 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.464 | |
| 4ftl | H0K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.464 | |
| 4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.464 | |
| 4qmu | SKE | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.464 | |
| 4u8i | FDA | UDP-galactopyranose mutase | / | 0.464 | |
| 5auv | AGI | Death-associated protein kinase 1 | 2.7.11.1 | 0.464 | |
| 1jeh | FAD | Dihydrolipoyl dehydrogenase, mitochondrial | 1.8.1.4 | 0.463 | |
| 2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.463 | |
| 3b8q | 900 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.463 | |
| 3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.463 | |
| 3q9y | TXQ | Casein kinase II subunit alpha | 2.7.11.1 | 0.463 | |
| 4a2z | VIQ | Glycylpeptide N-tetradecanoyltransferase | / | 0.463 | |
| 4bcr | WY1 | Peroxisome proliferator-activated receptor alpha | / | 0.463 | |
| 4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.463 | |
| 4jlm | 1NN | Deoxycytidine kinase | 2.7.1.74 | 0.463 | |
| 4qmt | H1N | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.463 | |
| 4wdb | 2AM | 2',3'-cyclic-nucleotide 3'-phosphodiesterase | 3.1.4.37 | 0.463 | |
| 1dq9 | HMG | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 1.1.1.34 | 0.462 | |
| 2o65 | MYF | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.462 | |
| 2pmo | HMD | Protein kinase 7 | / | 0.462 | |
| 3obg | SB2 | Mitogen-activated protein kinase 14 | / | 0.462 | |
| 3owj | 1EL | Casein kinase II subunit alpha | 2.7.11.1 | 0.462 | |
| 3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.462 | |
| 4aw5 | 30K | Ephrin type-B receptor 4 | 2.7.10.1 | 0.462 | |
| 4c57 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.462 | |
| 4fz7 | 0VH | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.462 | |
| 4g6n | EK0 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.462 | |
| 4h4u | NDP | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.462 | |
| 1bxq | PP8 | Penicillopepsin-1 | 3.4.23.20 | 0.461 | |
| 2wec | PP5 | Penicillopepsin-1 | 3.4.23.20 | 0.461 | |
| 2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.461 | |
| 2ym8 | YM8 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.461 | |
| 3bkb | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.461 | |
| 3iw4 | LW4 | Protein kinase C alpha type | 2.7.11.13 | 0.461 | |
| 3k3e | PDB | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.461 | |
| 3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.461 | |
| 4c58 | 824 | Cyclin-G-associated kinase | 2.7.11.1 | 0.461 | |
| 4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.461 | |
| 4ft5 | H2K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.461 | |
| 4hgs | 15G | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.461 | |
| 4i6a | HMG | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 1.1.1.88 | 0.461 | |
| 4xhg | ADP | Uncharacterized protein | / | 0.461 | |
| 4y8w | STR | Steroid 21-hydroxylase | / | 0.461 | |
| 1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.460 | |
| 1php | ADP | Phosphoglycerate kinase | 2.7.2.3 | 0.460 | |
| 1rek | B8L | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.460 | |
| 2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
| 2i0y | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.460 | |
| 2pmn | K51 | Protein kinase 7 | / | 0.460 | |
| 2r5t | ANP | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.460 | |
| 3be9 | P04 | Casein kinase II subunit alpha | 2.7.11.1 | 0.460 | |
| 3ezv | EZV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
| 3gst | GPR | Glutathione S-transferase Mu 1 | 2.5.1.18 | 0.460 | |
| 3itz | P66 | Mitogen-activated protein kinase 14 | / | 0.460 | |
| 3lpb | NVB | Tyrosine-protein kinase JAK2 | / | 0.460 | |
| 4a31 | 2CB | Glycylpeptide N-tetradecanoyltransferase | / | 0.460 | |
| 4ajw | VWN | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | 2.7.1.153 | 0.460 | |
| 4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.460 | |
| 4ieb | ANP | Calmodulin-domain protein kinase 1 | / | 0.460 | |
| 4oac | ADP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.460 | |
| 5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.460 | |
| 5dqr | FAD | 7-hydroxymethyl chlorophyll a reductase, chloroplastic | 1.17.7.2 | 0.460 | |
| 1h1r | 6CP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
| 1k6p | XN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.459 | |
| 2e9o | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
| 2pvr | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.459 | |
| 2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.459 | |
| 2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.459 | |
| 2yaa | ATP | Death-associated protein kinase 2 | / | 0.459 | |
| 3g0f | B49 | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.459 | |
| 3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.459 | |
| 3nyn | SGV | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.459 | |
| 3s2p | PMU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
| 3zsi | 52P | Mitogen-activated protein kinase 14 | / | 0.459 | |
| 4bb3 | KKA | Isopenicillin N synthase | 1.21.3.1 | 0.459 | |
| 4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.459 | |
| 4neu | Q1A | Receptor-interacting serine/threonine-protein kinase 1 | 2.7.11.1 | 0.459 | |
| 1lik | ADN | Adenosine kinase | 2.7.1.20 | 0.458 | |
| 1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
| 1yw2 | PGJ | Mitogen-activated protein kinase 14 | / | 0.458 | |
| 2a4z | BYM | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.458 | |
| 2c7g | FAD | NADPH-ferredoxin reductase FprA | 1.18.1.2 | 0.458 | |
| 2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
| 2hxq | 373 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
| 2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.458 | |
| 3ag9 | A02 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.458 | |
| 3cd3 | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.458 | |
| 3d8v | UD1 | Bifunctional protein GlmU | / | 0.458 | |
| 3fmh | 533 | Mitogen-activated protein kinase 14 | / | 0.458 | |
| 3hdm | MMG | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.458 | |
| 3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.458 | |
| 4eiy | ZMA | Adenosine receptor A2a | / | 0.458 | |
| 4i0t | 1B6 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.458 | |
| 4kb8 | 1QN | Casein kinase I isoform delta | 2.7.11.1 | 0.458 | |
| 1r0e | DFN | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.457 | |
| 2nru | T12 | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.457 | |
| 2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
| 3d7t | STU | Tyrosine-protein kinase CSK | / | 0.457 | |
| 3dog | NNN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
| 3qa2 | XNA | Ketohexokinase | / | 0.457 | |
| 3zsh | 469 | Mitogen-activated protein kinase 14 | / | 0.457 | |
| 4a99 | FAD | TetX family tetracycline inactivation enzyme | / | 0.457 | |
| 4a9s | RU9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.457 | |
| 4bdb | ODO | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.457 | |
| 4fkw | 62K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
| 4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
| 4fsu | HK5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
| 4fz6 | 0VG | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.457 | |
| 4wx1 | FDA | UDP-galactopyranose mutase | / | 0.457 | |
| 1gii | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
| 1ie4 | T44 | Transthyretin | / | 0.456 | |
| 1mg5 | NAI | Alcohol dehydrogenase | 1.1.1.1 | 0.456 | |
| 1sm2 | STU | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.456 | |
| 1xws | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.456 | |
| 1ywn | LIF | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.456 | |
| 2cch | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
| 2qd9 | LGF | Mitogen-activated protein kinase 14 | / | 0.456 | |
| 3fi4 | FI4 | Mitogen-activated protein kinase 14 | / | 0.456 | |
| 3nug | NAD | Pyridoxal 4-dehydrogenase | 1.1.1.107 | 0.456 | |
| 3q92 | XNB | Ketohexokinase | / | 0.456 | |
| 3qd4 | 3Q6 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.456 | |
| 3qf9 | NM8 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.456 | |
| 3rvg | 17P | Tyrosine-protein kinase JAK2 | / | 0.456 | |
| 3tne | RIT | Candidapepsin-1 | 3.4.23.24 | 0.456 | |
| 3ule | C69 | Actin-related protein 3 | / | 0.456 | |
| 3vew | ADP | nebramycin 5' synthase | 6.1.2.2 | 0.456 | |
| 4a6n | FAD | TetX family tetracycline inactivation enzyme | / | 0.456 | |
| 4d0l | 093 | Phosphatidylinositol 4-kinase beta | 2.7.1.67 | 0.456 | |
| 4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.456 | |
| 4l52 | 1UL | Mitogen-activated protein kinase kinase kinase 7 | 2.7.11.25 | 0.456 | |
| 4nxv | GDP | Mitochondrial dynamics protein MID51 | / | 0.456 | |
| 5av2 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.456 | |
| 1ia3 | TQ5 | Dihydrofolate reductase | 1.5.1.3 | 0.455 | |
| 1kbo | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.455 | |
| 1uvr | BI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.455 | |
| 1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.455 | |
| 1zmc | NAD | Dihydrolipoyl dehydrogenase, mitochondrial | 1.8.1.4 | 0.455 | |
| 2biy | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.455 | |
| 2f4b | EHA | Peroxisome proliferator-activated receptor gamma | / | 0.455 | |
| 2wtd | ZZK | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.455 | |
| 2ym5 | YM5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
| 3dy8 | 5GP | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.455 | |
| 3fmn | 530 | Mitogen-activated protein kinase 14 | / | 0.455 | |
| 3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.455 | |
| 3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
| 3q5i | ANP | Protein kinase, putative | / | 0.455 | |
| 3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
| 3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
| 4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.455 | |
| 4dfl | 0K0 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.455 | |
| 4eut | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.455 | |
| 4ftj | H8K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
| 4joa | 3DK | ALK tyrosine kinase receptor | 2.7.10.1 | 0.455 | |
| 4o70 | 1QK | Bromodomain-containing protein 4 | / | 0.455 | |
| 4qmy | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.455 | |
| 5cvf | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.455 | |
| 5k2c | ZMA | Adenosine receptor A2a | / | 0.455 | |
| 3qak | UKA | Adenosine receptor A2a | / | 0.455 | |
| 1hvr | XK2 | Gag-Pol polyprotein | / | 0.454 | |
| 1oi9 | N20 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
| 1uv5 | BRW | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.454 | |
| 2hdh | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.454 | |
| 2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.454 | |
| 2w9s | TOP | Dihydrofolate reductase type 1 from Tn4003 | 1.5.1.3 | 0.454 | |
| 2x3n | FAD | Probable FAD-dependent monooxygenase | / | 0.454 | |
| 2x4z | X4Z | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.454 | |
| 2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.454 | |
| 2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.454 | |
| 2zjw | REF | Casein kinase II subunit alpha | 2.7.11.1 | 0.454 | |
| 3qcs | 3Q1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.454 | |
| 3rak | 03Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
| 3tmz | 06X | Cytochrome P450 2B4 | 1.14.14.1 | 0.454 | |
| 3u8w | 09J | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 3w1f | 1O5 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.454 | |
| 4bdg | P3J | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.454 | |
| 4cax | 646 | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.454 | |
| 4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.454 | |
| 4gh6 | LUO | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.454 | |
| 4h38 | 0YX | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.454 | |
| 4ock | ANP | N-acetylhexosamine 1-kinase | 2.7.1.162 | 0.454 | |
| 4xld | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.454 | |
| 5hwr | COA | Hydroxymethylglutaryl-CoA synthase | / | 0.454 | |
| 1i6x | CMP | cAMP-activated global transcriptional regulator CRP | / | 0.453 | |
| 1okz | UCN | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.453 | |
| 2fto | CB3 | Thymidylate synthase | / | 0.453 | |
| 2j0k | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.453 | |
| 2wmv | ZYV | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
| 3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.453 | |
| 3cr0 | 809 | Wee1-like protein kinase | 2.7.10.2 | 0.453 | |
| 3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.453 | |
| 3qw2 | NAD | Myo-inositol-1-phosphate synthase (Ino1) | / | 0.453 | |
| 3ump | ATP | ATP-dependent 6-phosphofructokinase isozyme 2 | 2.7.1.11 | 0.453 | |
| 3zpt | M8Y | Gag-Pol polyprotein | 3.4.23.16 | 0.453 | |
| 4f4p | 0SB | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.453 | |
| 4gfo | 0X2 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.453 | |
| 4pd6 | URI | Nucleoside permease | / | 0.453 | |
| 4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.453 | |
| 5auu | LU2 | Death-associated protein kinase 1 | 2.7.11.1 | 0.453 | |
| 5c03 | AGS | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.453 | |
| 5k2a | ZMA | Adenosine receptor A2a | / | 0.453 | |
| 1e8x | ATP | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.452 | |
| 1u3c | FAD | Cryptochrome-1 | / | 0.452 | |
| 2bl4 | NAD | Lactaldehyde reductase | 1.1.1.77 | 0.452 | |
| 2c3l | IDZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.452 | |
| 3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.452 | |
| 3bfb | 9OD | Pheromone-binding protein ASP1 | / | 0.452 | |
| 3bqr | 4RB | Death-associated protein kinase 3 | / | 0.452 | |
| 3hdh | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.452 | |
| 3jy0 | LYG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.452 | |
| 4an2 | EUI | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.452 | |
| 4bgh | 3I6 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
| 4bi1 | ZO6 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.452 | |
| 4f1s | F1S | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.452 | |
| 4ftn | 2HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
| 4fv0 | EK3 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.452 | |
| 4ia2 | BIV | Vitamin D3 receptor A | / | 0.452 | |
| 4tuv | CPZ | Cytochrome P450 119 | 1.14 | 0.452 | |
| 1hnc | GDN | Glutathione S-transferase Mu 2 | 2.5.1.18 | 0.451 | |
| 1xkd | NAP | Isocitrate dehydrogenase [NADP] | / | 0.451 | |
| 2vmy | FFO | Serine hydroxymethyltransferase | / | 0.451 | |
| 2y9q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.451 | |
| 3cs8 | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.451 | |
| 3gc8 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.451 | |
| 3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.451 | |
| 3i59 | N6R | CRP-like cAMP-activated global transcriptional regulator | / | 0.451 | |
| 3nmp | PYV | Abscisic acid receptor PYL2 | / | 0.451 | |
| 3oqf | S51 | Renin | 3.4.23.15 | 0.451 | |
| 3vid | 4TT | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.451 | |
| 4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.451 | |
| 4l7f | 1V5 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.451 | |
| 4loo | SB4 | Mitogen-activated protein kinase 14 | / | 0.451 | |
| 4tnb | SGV | G protein-coupled receptor kinase 5 | 2.7.11.16 | 0.451 | |
| 4tyj | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.451 | |
| 5av3 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.451 | |
| 5csh | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.451 | |
| 1uyk | PUX | Heat shock protein HSP 90-alpha | / | 0.450 | |
| 1yvj | 4ST | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.450 | |
| 1zmd | NAI | Dihydrolipoyl dehydrogenase, mitochondrial | 1.8.1.4 | 0.450 | |
| 2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
| 2hb7 | O1C | Vitamin D3 receptor | / | 0.450 | |
| 2v52 | LAB | Actin, alpha skeletal muscle | / | 0.450 | |
| 2wti | WTI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.450 | |
| 2z2w | 770 | Wee1-like protein kinase | 2.7.10.2 | 0.450 | |
| 3apf | BMW | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.450 | |
| 3dqw | AGS | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.450 | |
| 3ns2 | PYV | Abscisic acid receptor PYL2 | / | 0.450 | |
| 3q3c | NAD | NAD-dependent L-serine dehydrogenase | / | 0.450 | |
| 3qai | XNN | Ketohexokinase | / | 0.450 | |
| 4em9 | TCE | Peroxisome proliferator-activated receptor gamma | / | 0.450 | |
| 4enx | Z20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.450 | |
| 4ftr | 5HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
| 4fv1 | EK4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.450 | |
| 4ocv | ANP | Aminoglycoside phosphotransferase | / | 0.450 | |
| 5c6c | CMP | cGMP-dependent protein kinase 2 | 2.7.11.12 | 0.450 | |
| 1drh | NAP | Dihydrofolate reductase | 1.5.1.3 | 0.449 | |
| 1equ | EQI | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.449 | |
| 1fm9 | 570 | Peroxisome proliferator-activated receptor gamma | / | 0.449 | |
| 1kgj | FL8 | Transthyretin | / | 0.449 | |
| 1men | GAR | Trifunctional purine biosynthetic protein adenosine-3 | 2.1.2.2 | 0.449 | |
| 2cmv | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.449 | |
| 2g1p | SAH | DNA adenine methylase | 2.1.1.72 | 0.449 | |
| 2ow3 | BIM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.449 | |
| 3a1n | NAD | NDP-sugar epimerase | / | 0.449 | |
| 3cr3 | ADP | PTS-dependent dihydroxyacetone kinase, ADP-binding subunit DhaL | 2.7 | 0.449 | |
| 3dj4 | UD1 | Bifunctional protein GlmU | / | 0.449 | |
| 3ggp | NAD | Prephenate dehydrogenase | / | 0.449 | |
| 3qyw | 6PB | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.449 | |
| 3r9u | FAD | Thioredoxin reductase | / | 0.449 | |
| 3zdi | UGJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.449 | |
| 4ach | KDI | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.449 | |
| 4axf | ANP | Inositol-pentakisphosphate 2-kinase | 2.7.1.158 | 0.449 | |
| 4c34 | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.449 | |
| 4ewq | MWL | Mitogen-activated protein kinase 14 | / | 0.449 | |
| 4f08 | 1RS | Tyrosine-protein kinase JAK2 | / | 0.449 | |
| 4kz0 | 1UJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
| 4twn | B96 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.449 | |
| 4tx9 | AMZ | Phosphoribosyl isomerase A | / | 0.449 | |
| 5auw | QUE | Death-associated protein kinase 1 | 2.7.11.1 | 0.449 | |
| 1bxo | PP7 | Penicillopepsin-1 | 3.4.23.20 | 0.448 | |
| 1dbv | NAD | Glyceraldehyde-3-phosphate dehydrogenase | / | 0.448 | |
| 1kbq | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.448 | |
| 1zgy | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.448 | |
| 3dyn | PCG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.448 | |
| 3hvc | GG5 | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 3ix9 | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
| 3pvu | QRW | Beta-adrenergic receptor kinase 1 | 2.7.11.15 | 0.448 | |
| 3uwq | U5P | Orotidine 5'-phosphate decarboxylase | / | 0.448 | |
| 4fad | 0TB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.448 | |
| 4fta | H5K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
| 4fyn | 0VE | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.448 | |
| 4ia3 | BIV | Vitamin D3 receptor A | / | 0.448 | |
| 4jx1 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.448 | |
| 4kbc | 1QJ | Casein kinase I isoform delta | 2.7.11.1 | 0.448 | |
| 4m15 | ADP | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.448 | |
| 4s34 | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.448 | |
| 4wbo | ANW | Rhodopsin kinase | / | 0.448 | |
| 1d2s | DHT | Sex hormone-binding globulin | / | 0.447 | |
| 1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.447 | |
| 1h69 | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.447 | |
| 1i8t | FAD | UDP-galactopyranose mutase | 5.4.99.9 | 0.447 | |
| 1oky | STU | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
| 1w2x | RCP | Acetyl-CoA carboxylase | / | 0.447 | |
| 3f5p | 741 | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.447 | |
| 3fmj | FMJ | Mitogen-activated protein kinase 14 | / | 0.447 | |
| 3hz1 | 37D | Heat shock protein HSP 90-alpha | / | 0.447 | |
| 3ibe | L64 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.447 | |
| 3l0l | HC3 | Nuclear receptor ROR-gamma | / | 0.447 | |
| 3qlr | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
| 3uxy | NAD | Short-chain dehydrogenase/reductase SDR | / | 0.447 | |
| 3w0i | O11 | Vitamin D3 receptor | / | 0.447 | |
| 4aic | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | / | 0.447 | |
| 4h03 | LAR | Actin, alpha skeletal muscle | / | 0.447 | |
| 4oj4 | DIF | Peroxisome proliferator-activated receptor gamma | / | 0.447 | |
| 4qms | 1N1 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.447 | |
| 4qmz | B49 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.447 | |
| 4xgx | ADP | FAD:protein FMN transferase | / | 0.447 | |
| 4ysw | FAD | Xanthine dehydrogenase/oxidase | / | 0.447 | |
| 5aab | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.447 | |
| 1di8 | DTQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 1ir3 | ANP | Insulin receptor | 2.7.10.1 | 0.446 | |
| 1iyz | NDP | Probable quinone oxidoreductase | / | 0.446 | |
| 1tqm | ANP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.446 | |
| 1u3d | FAD | Cryptochrome-1 | / | 0.446 | |
| 1uu3 | LY4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.446 | |
| 2aib | ERG | Beta-elicitin cinnamomin | / | 0.446 | |
| 2b1p | AIZ | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.446 | |
| 2c54 | NAD | GDP-mannose 3,5-epimerase | 5.1.3.18 | 0.446 | |
| 2cf6 | NAP | Cinnamyl alcohol dehydrogenase 5 | 1.1.1.195 | 0.446 | |
| 2jn3 | JN3 | Fatty acid-binding protein, liver | / | 0.446 | |
| 2xcl | ANP | Phosphoribosylamine--glycine ligase | / | 0.446 | |
| 3aox | EMH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.446 | |
| 3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.446 | |
| 3gxo | MQA | Mitomycin biosynthesis 6-O-methyltransferase | / | 0.446 | |
| 3i59 | N6S | CRP-like cAMP-activated global transcriptional regulator | / | 0.446 | |
| 3jw3 | TOP | Dihydrofolate reductase | / | 0.446 | |
| 3nu3 | 478 | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
| 3ras | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | / | 0.446 | |
| 3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.446 | |
| 4ezk | 0SD | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.446 | |
| 4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.446 | |
| 4g2j | 0WF | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.446 | |
| 4g34 | 924 | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.446 | |
| 4g3s | UD1 | Bifunctional protein GlmU | / | 0.446 | |
| 4gub | 0Y4 | Casein kinase II subunit alpha | 2.7.11.1 | 0.446 | |
| 4ipe | ANP | TNF receptor-associated protein 1 | / | 0.446 | |
| 4j54 | G52 | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
| 4jnq | FDA | Thioredoxin reductase | / | 0.446 | |
| 4oti | MI1 | Serine/threonine-protein kinase N1 | / | 0.446 | |
| 4qmp | DKI | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.446 | |
| 4xum | IMN | Peroxisome proliferator-activated receptor gamma | / | 0.446 | |
| 5f0a | 1FB | cGMP-dependent protein kinase, putative | / | 0.446 | |
| 1cde | GAR | Phosphoribosylglycinamide formyltransferase | / | 0.445 | |
| 1cjc | FAD | NADPH:adrenodoxin oxidoreductase, mitochondrial | 1.18.1.6 | 0.445 | |
| 1gij | 2PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 1h1w | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
| 1ke8 | LS4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 1l3i | SAH | Probable cobalt-precorrin-6B C(15)-methyltransferase (decarboxylating) | / | 0.445 | |
| 1me6 | IVS | Plasmepsin-2 | 3.4.23.39 | 0.445 | |
| 1yi4 | ADN | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
| 2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
| 2eva | ADN | Mitogen-activated protein kinase kinase kinase 7 | 2.7.11.25 | 0.445 | |
| 2hcd | BIV | Vitamin D3 receptor A | / | 0.445 | |
| 2pe1 | 517 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
| 2vwq | NAP | Glucose 1-dehydrogenase | / | 0.445 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.445 | |
| 2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
| 2zb1 | GK4 | Mitogen-activated protein kinase 14 | / | 0.445 | |
| 3bgp | VX1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
| 3jvh | HHV | 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | / | 0.445 | |
| 3jxw | LXG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
| 3l1s | Z92 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.445 | |
| 3le6 | 2BZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.445 | |
| 3nga | 3NG | Casein kinase II subunit alpha | 2.7.11.1 | 0.445 | |
| 3p4t | FAO | Putative acyl-CoA dehydrogenase | / | 0.445 | |
| 3qcq | 3Q0 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
| 3ukf | FDA | UDP-galactopyranose mutase | / | 0.445 | |
| 3zon | IK1 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.445 | |
| 4a9u | A9U | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.445 | |
| 4c61 | LMM | Tyrosine-protein kinase JAK2 | / | 0.445 | |
| 4fhh | 0U3 | Vitamin D3 receptor A | / | 0.445 | |
| 4fx3 | 60K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.445 | |
| 4i0r | 1B4 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.445 | |
| 4ipw | 1G7 | Mycocyclosin synthase | 1.14.21.9 | 0.445 | |
| 4jaj | XU1 | Aurora kinase A | 2.7.11.1 | 0.445 | |
| 5ar4 | SB2 | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.445 | |
| 6gsw | GPS | Glutathione S-transferase Mu 1 | 2.5.1.18 | 0.445 | |
| 1bsv | NDP | GDP-L-fucose synthase | / | 0.444 | |
| 1ezv | UQ6 | Cytochrome b | / | 0.444 | |
| 1h7w | FAD | Dihydropyrimidine dehydrogenase [NADP(+)] | 1.3.1.2 | 0.444 | |
| 1ie3 | NAD | Malate dehydrogenase | / | 0.444 | |
| 1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.444 | |
| 1rbm | KT5 | Trifunctional purine biosynthetic protein adenosine-3 | 2.1.2.2 | 0.444 | |
| 1sn5 | T3 | Transthyretin | / | 0.444 | |
| 1tqp | ATP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.444 | |
| 2ayp | 43A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
| 2bro | DF2 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
| 2chx | 090 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
| 2czf | XMP | Orotidine 5'-phosphate decarboxylase | 4.1.1.23 | 0.444 | |
| 2gfs | PQB | Mitogen-activated protein kinase 14 | / | 0.444 | |
| 2gtm | LID | Mitogen-activated protein kinase 14 | / | 0.444 | |
| 2ofv | 242 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.444 | |
| 2pvl | P55 | Casein kinase II subunit alpha | 2.7.11.1 | 0.444 | |
| 2vtq | LZA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 2wtc | VGM | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.444 | |
| 3dpd | 41A | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
| 3jsk | AHZ | Thiamine thiazole synthase | / | 0.444 | |
| 3kvx | FMY | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.444 | |
| 3nu5 | 478 | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
| 3orz | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.444 | |
| 3r6p | A8S | Abscisic acid receptor PYL10 | / | 0.444 | |
| 3w2r | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
| 3zze | 6XP | Hepatocyte growth factor receptor | 2.7.10.1 | 0.444 | |
| 4anu | EM7 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
| 4bb5 | HD2 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.444 | |
| 4eh3 | NAR | Mitogen-activated protein kinase 14 | / | 0.444 | |
| 4g16 | 0VM | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.444 | |
| 4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.444 | |
| 4idv | 13V | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.444 | |
| 4ifv | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.444 | |
| 4jay | FAD | UDP-N-acetylenolpyruvoylglucosamine reductase | / | 0.444 | |
| 4mq1 | 2C3 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.444 | |
| 4n3e | 2AN | Phenolic oxidative coupling protein | / | 0.444 | |
| 5aux | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.444 | |
| 1lhv | NOG | Sex hormone-binding globulin | / | 0.443 | |
| 1m2p | HNA | Casein kinase II subunit alpha | 2.7.11.1 | 0.443 | |
| 1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 1q5k | TMU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.443 | |
| 1v0p | PVB | Cell division control protein 2 homolog | 2.7.11.22 | 0.443 | |
| 1xl2 | 189 | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
| 2b7a | IZA | Tyrosine-protein kinase JAK2 | / | 0.443 | |
| 2bik | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.443 | |
| 2clq | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.443 | |
| 2cu0 | XMP | Inosine-5'-monophosphate dehydrogenase | / | 0.443 | |
| 2hw2 | RFP | Rifampin ADP-ribosyl transferase | / | 0.443 | |
| 2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.443 | |
| 2io6 | 330 | Wee1-like protein kinase | 2.7.10.2 | 0.443 | |
| 2ivp | ATP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.443 | |
| 2pvn | P63 | Casein kinase II subunit alpha | 2.7.11.1 | 0.443 | |
| 2q9f | C3S | Cholesterol 24-hydroxylase | / | 0.443 | |
| 2vz6 | FEF | Calcium/calmodulin-dependent protein kinase type II subunit alpha | 2.7.11.17 | 0.443 | |
| 2wms | ZYS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 2xck | MH4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.443 | |
| 2ylx | FAD | Phenylacetone monooxygenase | 1.14.13.92 | 0.443 | |
| 3a4p | DFQ | Hepatocyte growth factor receptor | 2.7.10.1 | 0.443 | |
| 3c0i | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.443 | |
| 3d7k | D7K | Benzaldehyde lyase | / | 0.443 | |
| 3d8b | ADP | Fidgetin-like protein 1 | 3.6.4 | 0.443 | |
| 3f8p | NAD | NADH oxidase/thioredoxin reductase | / | 0.443 | |
| 3h0s | B38 | Acetyl-CoA carboxylase | / | 0.443 | |
| 3ibq | ATP | Pyridoxal kinase | / | 0.443 | |
| 3nc9 | TR3 | Ketohexokinase | / | 0.443 | |
| 3nun | JMZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.443 | |
| 3sls | 77D | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.443 | |
| 3tqh | NDP | Quinone oxidoreductase | / | 0.443 | |
| 3vbq | 0F5 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.443 | |
| 3vtd | TKD | Vitamin D3 receptor | / | 0.443 | |
| 4amb | DUD | Putative glycosyl transferase | / | 0.443 | |
| 4bch | T7Z | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.443 | |
| 4fl1 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.443 | |
| 4im0 | 1FV | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.443 | |
| 4loq | SB4 | Mitogen-activated protein kinase 14 | / | 0.443 | |
| 4xiv | ACP | Chemotaxis protein CheA | 2.7.13.3 | 0.443 | |
| 4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.443 | |
| 5dp2 | NAP | CurF | / | 0.443 | |
| 1c2t | GAR | Phosphoribosylglycinamide formyltransferase | / | 0.442 | |
| 1hdg | NAD | Glyceraldehyde-3-phosphate dehydrogenase | / | 0.442 | |
| 1j7u | ANP | Aminoglycoside 3'-phosphotransferase | 2.7.1.95 | 0.442 | |
| 1lud | TRR | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
| 1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.442 | |
| 1qbg | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.442 | |
| 1zth | ADP | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.442 | |
| 2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.442 | |
| 2fvd | LIA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 2oh0 | 2PY | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.442 | |
| 2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.442 | |
| 2q61 | SF1 | Peroxisome proliferator-activated receptor gamma | / | 0.442 | |
| 2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.442 | |
| 2wtj | WTJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.442 | |
| 2x7g | PVB | SRSF protein kinase 2 | 2.7.11.1 | 0.442 | |
| 2x8e | X8E | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 2x8i | X8I | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.442 | |
| 3aty | FMN | Prostaglandin F2a synthase | / | 0.442 | |
| 3cqe | P91 | Wee1-like protein kinase | 2.7.10.2 | 0.442 | |
| 3inm | NDP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.442 | |
| 3nuo | 478 | Gag-Pol polyprotein | 3.4.23.16 | 0.442 | |
| 3pe2 | E1B | Casein kinase II subunit alpha | 2.7.11.1 | 0.442 | |
| 3s00 | Z60 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 3zep | 1NX | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.442 | |
| 4a4q | UX9 | Pol protein | / | 0.442 | |
| 4aox | FAD | Steroid monooxygenase | / | 0.442 | |
| 4ap3 | FAD | Steroid monooxygenase | / | 0.442 | |
| 4d4s | BI9 | Focal adhesion kinase 1 | 2.7.10.2 | 0.442 | |
| 4dpw | AGS | Mevalonate diphosphate decarboxylase | / | 0.442 | |
| 4e5k | NAD | Phosphonate dehydrogenase | 1.20.1.1 | 0.442 | |
| 4enh | FVX | Cholesterol 24-hydroxylase | / | 0.442 | |
| 4f9m | FCM | Peroxisome proliferator-activated receptor gamma | / | 0.442 | |
| 4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 4fto | 3HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 4g1z | 0VP | Vitamin D3 receptor A | / | 0.442 | |
| 4iak | ADP | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.442 | |
| 4nxw | ADP | Mitochondrial dynamics protein MID51 | / | 0.442 | |
| 1f4g | TP4 | Thymidylate synthase | / | 0.441 | |
| 1nhh | ANP | DNA mismatch repair protein MutL | / | 0.441 | |
| 1q1w | FAD | Putidaredoxin reductase | 1.18.1.5 | 0.441 | |
| 1r78 | FMD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 1xdd | AAY | Integrin alpha-L | / | 0.441 | |
| 2aaz | CB3 | Thymidylate synthase | 2.1.1.45 | 0.441 | |
| 2f2c | AP9 | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.441 | |
| 2wuf | KEM | 4,5:9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oate hydrolase | 3.7.1.17 | 0.441 | |
| 2zdu | 446 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.441 | |
| 3anm | SYD | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.441 | |
| 3el7 | PD3 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.441 | |
| 3f88 | 3HT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.441 | |
| 3gwf | FAD | Cyclohexanone monooxygenase | / | 0.441 | |
| 3iw5 | DF3 | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 3n1s | 5GP | Purine nucleoside phosphoramidase | / | 0.441 | |
| 3r3f | 4CO | 4-hydroxybenzoyl-CoA thioesterase | 3.1.2.23 | 0.441 | |
| 3sw7 | 19K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 3v5j | 0F2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.441 | |
| 3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 | |
| 4cnj | FAD | L-amino acid oxidase | / | 0.441 | |
| 4fa6 | 0TA | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.441 | |
| 4ft9 | H4K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
| 4ftq | 4HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
| 4gfg | 0XF | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.441 | |
| 4i2q | 1BT | Gag-Pol polyprotein | 2.7.7.49 | 0.441 | |
| 4ia1 | BIV | Vitamin D3 receptor A | / | 0.441 | |
| 4ia7 | BIV | Vitamin D3 receptor A | / | 0.441 | |
| 4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.441 | |
| 4ji9 | 1M3 | Tyrosine-protein kinase JAK2 | / | 0.441 | |
| 4jqe | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.441 | |
| 4tv3 | ML9 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | / | 0.441 | |
| 4y93 | 746 | Tyrosine-protein kinase | / | 0.441 | |
| 1bvr | THT | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.440 | |
| 1c3e | GAR | Phosphoribosylglycinamide formyltransferase | / | 0.440 | |
| 1fm7 | DFV | Chalcone--flavonone isomerase 1 | 5.5.1.6 | 0.440 | |
| 1k6v | XN2 | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
| 1p44 | GEQ | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.440 | |
| 1pvd | TPP | Pyruvate decarboxylase isozyme 1 | / | 0.440 | |
| 1uwh | BAX | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.440 | |
| 1w22 | NHB | Histone deacetylase 8 | 3.5.1.98 | 0.440 | |
| 1zys | 199 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 2azz | TCH | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.440 | |
| 2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 2o7p | NAP | Riboflavin biosynthesis protein RibD | / | 0.440 | |
| 2oby | NAP | Quinone oxidoreductase PIG3 | 1 | 0.440 | |
| 2pe2 | 464 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 | |
| 2r3p | 3SC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 2r43 | G3G | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
| 2yex | YEX | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
| 3c50 | ADP | Rhodopsin kinase | / | 0.440 | |
| 3cly | ACP | Fibroblast growth factor receptor 2 | / | 0.440 | |
| 3cy3 | JN5 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
| 3gbu | ATP | Uncharacterized sugar kinase PH1459 | 2.7.1 | 0.440 | |
| 3gfb | NAD | L-threonine 3-dehydrogenase | / | 0.440 | |
| 3ggg | NAD | Prephenate dehydrogenase | / | 0.440 | |
| 3k1j | ADP | ATP-dependent protease Lon | / | 0.440 | |
| 3l08 | ZIG | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
| 3ma3 | 01I | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
| 3nuu | JOZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 | |
| 3qqg | X06 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 3rm6 | 18Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 3sqw | ANP | ATP-dependent RNA helicase MSS116, mitochondrial | 3.6.4.13 | 0.440 | |
| 4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 | |
| 4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.440 | |
| 4bkj | STI | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.440 | |
| 4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 0.440 | |
| 4i0s | 1B5 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.440 | |
| 4iva | 1J5 | Tyrosine-protein kinase JAK2 | / | 0.440 | |
| 4zoh | FAD | Putative oxidoreductase FAD-binding subunit | / | 0.440 | |
| 4zse | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
| 5a4k | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.440 | |
| 5jla | NAD | Putative short-chain dehydrogenase/reductase | / | 0.440 | |
| 4uhr | NGI | Adenosine receptor A2a | / | 0.440 |